Are differentially expressed microRNAs useful in the diagnostics of malignant pleural mesothelioma?

APMIS

Volumn 120, Issue 9, 2012, Pages 767-769

  Andersen, Morten ^a   Grauslund, Morten ^a   Muhammad Ali, Marwa ^a   Ravn, Jesper ^a   Sørensen, Jens Benn ^a   Andersen, Claus B ^a   Santoni Rugiu, Eric ^a  

^a University of Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; FORMALDEHYDE; GEMCITABINE; MICRORNA; MICRORNA 17 5P; MICRORNA 221; MICRORNA 222; MICRORNA 30C; NAVELBINE; PARAFFIN; UNCLASSIFIED DRUG;

ADULT; AGED; AREA UNDER THE CURVE; CANCER CELL CULTURE; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CELL IMMORTALIZATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DOWN REGULATION; EPITHELIOID CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LETTER; LUNG ADENOCARCINOMA; LUNG RESECTION; MALE; MESOTHELIUM CELL; MULTIPLE CYCLE TREATMENT; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; RANK SUM TEST; REACTIVE MESOTHELIAL PROLIFERATION; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SARCOMATOID CARCINOMA; SENSITIVITY AND SPECIFICITY; UPREGULATION; WILCOXON SIGNED RANKS TEST;

AGED; FEMALE; HUMANS; MALE; MESOTHELIOMA; MICRORNAS; MIDDLE AGED; PLEURAL NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84865296593     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2012.02891.x     Document Type: Letter

References (13)

1. Husain AN, Colby TV, Ordóñez NG, Krausz T, Borczuk A, Cagle PT, et al. Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med 2009;133:1317-31.
2. Shi M, Fraire AE, Chu P, Cornejo K, Woda BA, Dresser KA, et al. Oncofetal protein IMP3, a new diagnostic biomarker to distinguish malignant mesothelioma from reactive mesothelial proliferation. Am J Surg Pathol 2011;35:878-82.
3. Zimling ZG, Jørgensen A, Santoni-Rugiu E. The diagnostic value of immunohistochemically detected methylthioadenosine phosphorylase deficiency in malignant pleural mesotheliomas. Histopathology 2012; 60:e96-105.
4. Sayed D, Abdellatif M. MicroRNAs in development and disease. Physiol Rev 2011;91:827-87.
5. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006;103:2257-61.
6. Siebolts U, Varnholt H, Drebber U, Dienes HP, Wickenhauser C, Odenthal M. Tissues from routine pathology archives are suitable for micro-RNA analyses by quantitative PCR. J Clin Pathol 2009;62:84-8.
7. Santarelli L, Strafella E, Staffolani S, Amati M, Emanuelli M, Sartini D, et al. Association of MiR-126 with soluble mesothelin-related peptides, a marker for malignant mesothelioma. PLoS One 2011;6:e18232.
8. Balatti V, Maniero S, Ferracin M, Veronese A, Negrini M, Ferrocci G, et al. MicroRNAs dysregulation in human malignant pleural mesothelioma. J Thorac Oncol 2011;6:844-51.
9. Benjamin H, Lebanony D, Rosenwald S, Cohen L, Gibori H, Barabash N, et al. A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma. J Mol Diagn 2010;12:771-9.
10. Gee GV, Koestler DC, Christensen BC, Sugarbaker DJ, Ugolini D, Ivaldi GP, et al. Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma. Int J Cancer 2010;127:2859-69.
11. Busacca S, Germano S, De Cecco L, Rinaldi M, Comoglio F, Favero F, et al. MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications. Am J Respir Cell Mol Biol 2010;42:312-9.
12. Mineo TC, Ambrogi V, Cufari ME, Pompeo E. May cyclooxygenase-2 (COX-2), p21 and p27 expression affect prognosis and therapeutic strategy of patients with malignant pleural mesothelioma? Eur J Cardiothorac Surg 2010;38:245-52.
13. Opitz I, Soltermann A, Abaecherli M, Hinterberger M, Probst-Hensch N, Stahel R, et al. PTEN expression is a strong predictor of survival in mesothelioma patients. Eur J Cardiothorac Surg 2008;33:502-6.